Intervention Review

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

  1. Richard P Mattick1,*,
  2. Jo Kimber1,
  3. Courtney Breen1,
  4. Marina Davoli2

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 5 DEC 2007

DOI: 10.1002/14651858.CD002207.pub3

How to Cite

Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD002207. DOI: 10.1002/14651858.CD002207.pub3.

Author Information

  1. 1

    University of New South Wales, National Drug and Alcohol Research Centre, Sydney, New South Wales, Australia

  2. 2

    Dept. of Epidemiology ASL RME, Italy, Cochrane Drugs and Alcohol Group, Rome, Italy

*Richard P Mattick, National Drug and Alcohol Research Centre, University of New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, 2052, Australia. r.mattick@unsw.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

  1. Current Version

    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Richard P Mattick, Jo Kimber, Courtney Breen and Marina Davoli

    Article first published online: 16 JUL 2008 | DOI: 10.1002/14651858.CD002207.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    RP Mattick, J Kimber, C Breen and M Davoli

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD002207.pub2

  2. Version 1

    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    RP Mattick, J Kimber, C Breen and M Davoli

    Article first published online: 22 APR 2003 | DOI: 10.1002/14651858.CD002207